Search results
Diagnosing Multiple Sclerosis: 5 Things to Know
Medscape· 1 day agoIn the United States, nearly 1 million people are living with multiple sclerosis (MS), an immune-mediated inflammatory disease that causes demyelination...
Multiple Sclerosis Highlights From AAN 2024
Medscape· 3 days agoHighlights in relapsing-remitting multiple sclerosis from AAN 2024 include pregnancy-related considerations, anti-CD20 drug-associated infection, and...
A Baffling Rise In MS Cases Has Doctors Seeking Answers To The ‘Billion Dollar Question’
Women's Health via Yahoo News· 1 day agoMultiple Sclerosis diagnoses have been rising globally since 2013, and in 2019, an estimated 1...
UC San Francisco Scientists Find Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms...
Sierra Sun Times· 4 days agoMay 6, 2024 - By Levi Gadye - In a discovery that could hasten treatment for patients with multiple ...
Q1 2024 Royalty Pharma PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 hours agoBut in summary, we have agreed to acquire royalties and milestones on Sanofi's frexalimab for approximately $525 million, including estimated transaction costs. This is an exciting development ...
Hundreds walk at Glen Island Park to raise money for multiple sclerosis research
The Daily Sentinel· 5 days agoThe president of the Greater New York City and Long Island chapter of the National Multiple ...
Research shows interferon-beta regulates excessive alternative splicing in multiple sclerosis
Medical Xpress· 7 days agoA new study found extensive alternative splicing of messenger RNA in the blood cells of untreated multiple sclerosis patients compared to healthy controls ...
Immunic advances ‘potentially groundbreaking’ MS therapy vidofludimus calcium during Q1
Proactive Investors· 2 days agoImmunic Inc (NASDAQ:IMUX) continued to advance its clinical programs for its lead drug asset,...
Colorado hospitals detect 3 cases of infections linked to stem-cell treatments received in Mexico
Denver Post· 36 minutes agoThe first case was reported in late 2022, in a woman who had embryonic stem-cell treatment in...
Clene (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation Highlights
Digital Journal· 22 hours agoClene Nanomedicine is a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases. Highlights of the report include the news that data ...